Skip to main content
SpringerLink
Log in

Prolactin Excess and Deficiency: Epidemiology, Causes (Excluding Prolactin-Secreting Pituitary Tumors)

  • Chapter
  • First Online:
Prolactin Disorders

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Prolactin excess, defined as an increase of serum prolactin above the laboratory reference limit, is a frequent problem in endocrine practice. It affects females predominantly, but occurs in both males and females. Although in many situations hyperprolactinemia is physiological (pregnancy, lactation, nipple stimulation, or stress), it can be the consequence of a pathological condition or a drug. Any situation leading to a decreased dopaminergic inhibition of prolactin secretion or to a reduction of prolactin clearance can cause hyperprolactinemia. Psychotropic drugs, like antipsychotics or some antidepressants, are among the most frequently reported etiologies. However, occasionally the cause of prolactin excess remains unknown, and these cases are diagnosed as idiopathic hyperprolactinemias.

Prolactin deficiency refers to decreased or absent serum levels of prolactin due to a loss of function of lactotroph pituitary cells. Epidemiological data of prolactin deficiency are scarce because of a relative perceived lack of clinical significance compared with other pituitary hormones. Isolated prolactin deficiency is rare; most patients have evidence of other pituitary hormone deficiencies. Sheehan’s syndrome, which usually presents with inability to breastfeed, is one of the most recognized causes of hypoprolactinemia.

Finally, although prolactin disorders are mostly acquired, a genetic etiology may be possible and has to be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bernichtein S, Touraine P, Goffin V. New concepts in prolactin biology. J Endocrinol. 2010;206(1):1–11.

    Article  CAS  Google Scholar 

  2. Molitch ME, Schwartz S, Mukherji B. Is prolactin secreted ectopically? Am J Med. 1981;70(4):803–7.

    Article  CAS  Google Scholar 

  3. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–88.

    Article  CAS  Google Scholar 

  4. Peuskens J, Pani L, Detraux J, De Hert M. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. CNS Drugs. 2014;28:421–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Soto-Pedre E, Newey PJ, Bevant JS, Greig N, Leese GP. The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS). Clin Endocrinol (Oxf). 2017;86:60–7.

    Article  CAS  Google Scholar 

  6. Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin N Am. 2008;37(1):67–99.

    Article  CAS  Google Scholar 

  7. Vilar L, Freitas MC, Naves LA, et al. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Investig. 2008;31:436–44.

    Article  CAS  Google Scholar 

  8. Scranton RA, Baskin DS. Impaired pituitary axes following traumatic brain injury. J Clin Med. 2015;4:1463–79.

    Article  CAS  Google Scholar 

  9. Seshadri MS, Sud A, Chandy MJ, Thomas J, Kanagasbapahy AS, Cherian AM. Hyperprolactinemia in women- a series of 71 cases. J Assoc Physicians India. 1993;41:706–7.

    CAS  PubMed  Google Scholar 

  10. Sonino N, Navarrini C, Ruini C, Fallo F, Boscaro M, Fava GA. Life events in the pathogenesis of hyperprolactinemia. Eur J Endocrinol. 2004;151:61–5.

    Article  CAS  Google Scholar 

  11. Berinder K, Stackenäs I, Akre O, Hirschberg AL, Hulting AL. Hyperprolactinemia in 271 women: up to three decades of clinical follow-up. Clin Endocrinol (Oxf). 2005;63(4):450–5.

    Article  Google Scholar 

  12. Zargar AH, Laway BA, Massodi SR, et al. Clinical and etiological profile of hyperprolactinemia-data from a tertiary care centre. J Assoc Physicians India. 2005;53:288–90.

    CAS  PubMed  Google Scholar 

  13. Saejong R, Dangrat C, Techatrisak K, Angsuwatthana S, Rattanachaivanont M, Tanmahasamut P. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj hospital. J Med Assoc Thail. 2013;96:1247–56.

    Google Scholar 

  14. Dekkers OM, Ehrenstein V, Bengtsen M, et al. Breast cancer risk in hyperprolactinemia: a population-based cohort study and meta-analysis of the literature. Eur J Endocrinol. 2015;173:269–73.

    Article  CAS  Google Scholar 

  15. Tyson JE, Hwang P, Guyda H, Friesen HG. Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol. 1972;113(1):14–20.

    Article  CAS  Google Scholar 

  16. Molitch ME. Disorders of prolactin secretion. Endocrinol Metab Clin N Am. 2001;30(3):585–610.

    Article  CAS  Google Scholar 

  17. Newey PJ, Gorvin CM, Cleland SJ, et al. Mutant prolactin receptor and familial hyperprolactinemia. N Engl J Med. 2013;369:2012–20.

    Article  CAS  Google Scholar 

  18. Robin G, Catteau-Jonard S, Young J, Dewailly D. Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality? Gynecol Obstet Fertil. 2011;39(3):141–5.

    Article  Google Scholar 

  19. Bracero N, Zacur HA. Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin N Am. 2001;28(1):77–84.

    Article  CAS  Google Scholar 

  20. Filho RB, Domingues L, Naves L, Ferraz E, Alves A, Casulari LA. Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol Endocrinol. 2007;23(5):267–72.

    Article  Google Scholar 

  21. Stryker TD, Molitch ME. Reversible hyperthyrotropinemia, hyperthyroxinemia, and hyperprolactinemia due to adrenal insufficiency. Am J Med. 1985;79(2):271–6.

    Article  CAS  Google Scholar 

  22. Mackin P, Waton A, Nulkar A, Watkinson HM. Prolactin and smoking status in antipsychotic-treated patients. J Psychopharmacol. 2011;25(5):698–703.

    Article  CAS  Google Scholar 

  23. Romeo JH, Dombrowski R, Kwak YS, Fuehrer S, Aron DC. Hyperprolactinaemia and verapamil: prevalence and potential association with hypogonadism in men. Clin Endocrinol (Oxf). 1996;45:571–5.

    Article  CAS  Google Scholar 

  24. Veselinovic T, Schorn H, Vernaleken IB, Schiffl K, Klomp M, Gründer G. Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion. J Clin Psychopharmacol. 2011;31(2):214–20.

    Article  CAS  Google Scholar 

  25. Merdin A, Merdin FA, Gündüz S, Bozcuk H, Coskun HS. Opioid endocrinopathy: a clinical problem in patients with cancer pain. Exp Ther Med. 2016;11(5):1819–22.

    Article  CAS  Google Scholar 

  26. Patkar AA, Mannelli P, Certa KM, et al. Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence. Psychopharmacology (Berl). 2004;176(1):74–81.

    Article  CAS  Google Scholar 

  27. Meltzer HY, Maes M, Lee MA. The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine. Psychopharmacology (Berl). 1993;112(1 Suppl):S95–104.

    Article  CAS  Google Scholar 

  28. Kauppila A, Martikainen H, Puistola U, Reinila M, Romberg L. Hypoprolactinemia and ovarian function. Fertil Steril. 1988;49:437–41.

    Article  CAS  Google Scholar 

  29. Rastrelli G, Corona G, Maggi M. The role of prolactin in andrology: what is new? Rev Endocr Metab Disord. 2015;16(3):233–48.

    Article  CAS  Google Scholar 

  30. Mukherjee A, Murray RD, Columb B, Gleeson HK, Shalet SM. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis. Clin Endocrinol (Oxf). 2003;59:743–8.

    Article  Google Scholar 

  31. Regal M, Páramo C, Sierra SM, García-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001;55(6):735–40.

    Article  CAS  Google Scholar 

  32. Pekic S, Popovic V. Diagnosis of endocrine disease: expanding the cause of hypopituitarism. Eur J Endocrinol. 2017;176(6):R269–82.

    Article  CAS  Google Scholar 

  33. Romero CJ, Pine-Twaddell E, Radovick S. Novel mutations associated with combined pituitary hormone deficiency. J Mol Endocrinol. 2011;46(3):R93–102.

    Article  CAS  Google Scholar 

  34. Rosebloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab. 1999;84:50–7.

    Google Scholar 

  35. Cogan JD, Wu W, Phillips JA 3rd, Arnhold IJ, Agapito A, Fofanova OV, et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab. 1998;83:3346–9.

    CAS  PubMed  Google Scholar 

  36. Carlson HE, Brickman AS, Bottazo GF. Prolactin deficiency in pseudohypoparathyroidism. N Engl J Med. 1977;296(3):140–4.

    Article  CAS  Google Scholar 

  37. Douchi T, Nakae M, Yamamoto S, Iwamoto I, Oki T, Nagata Y. A woman with isolated prolactin deficiency. Acta Obstet Gynecol Scand. 2001;80(4):368–70.

    CAS  PubMed  Google Scholar 

  38. Zargar AH, Masoodi SR, Laway BA, Shah NA, Salahudin M. Familial puerperal alactogenesis: possibility of a genetically transmitted isolated prolactin deficiency. Br J Obstet Gynaecol. 1997;104(5):629–31.

    Article  CAS  Google Scholar 

  39. Iwama S, Welt CK, Romero CJ, Radovick S, Caturegli P. Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J Clin Endocrinol Metab. 2013;98(10):3920–5.

    Article  CAS  Google Scholar 

  40. Daniel JS, Govindan JP, Kamath C, D’Souza C, Adlan MA, Premawardhana LD. Newer dopaminergic agents cause minimal endocrine effects in idiopathic Parkinson’s disease. Clin Med Insights Endocrinol Diabetes. 2014;7:13–7.

    Article  CAS  Google Scholar 

  41. Lozano R, Marín R, Santacruz MJ. Prolactin deficiency by aripiprazole. J Clin Psychopharmacol. 2014;34:539–40.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine – Endocrinology, University Hospital of Santiago, Santiago de Compostela, Spain

    Rocío Villar Taibo, Mildred Sifontes Dubon, Ignacio Bernabeu Morón & Felipe F. Casanueva

  2. University of Santiago, and Centro de Investigación Biomédica en Red Obesity-Nutrition, Santiago de Compostela, Spain

    Felipe F. Casanueva

  3. Department of Medicine, Santiago de Compostela University, Complejo Hospitalario Universitario de Santiago (CHUS), CIBER de Fisiopatologia Obesidad y Nutrición (CIBERobn), Instituto Salud Carlos III, Santiago de Compostela, Spain

    Felipe F. Casanueva

Authors
  1. Rocío Villar Taibo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mildred Sifontes Dubon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ignacio Bernabeu Morón
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Felipe F. Casanueva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Felipe F. Casanueva .

Editor information

Editors and Affiliations

  1. Neuroendocrine and Pituitary Clinical Center, Massachusetts General Hospital, Boston, MA, USA

    Nicholas A. Tritos

  2. Neuroendocrine and Pituitary Clinical Center, Massachusetts General Hospital, Boston, MA, USA

    Anne Klibanski

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Villar Taibo, R., Sifontes Dubon, M., Morón, I.B., Casanueva, F.F. (2019). Prolactin Excess and Deficiency: Epidemiology, Causes (Excluding Prolactin-Secreting Pituitary Tumors). In: Tritos, N., Klibanski, A. (eds) Prolactin Disorders. Contemporary Endocrinology. Humana, Cham. https://doi.org/10.1007/978-3-030-11836-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11836-5_5

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-11835-8

  • Online ISBN: 978-3-030-11836-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation